Chao Wu has 25 years of industry experience in the China pharmaceutical industry.
He has established track record in sales and marketing managing products in a wide spectrum of therapeutic areas including rare diseases, oncology, infection and ophthalmology etc.in Pfizer & Roche.
He served as the Rare diseases lead of Sanofi Genzyme China prior to joining Sperogenix overseeing sales, marketing, patient support, as well as market access. He received Bachelor's degree in biopharmaceutical from China Pharmaceutical University, MBA from Peking University.
address: A-216, No.56 Dongzhimen Wai Xie St. Chaoyang, Beijing 100027, China
tel: +86 10 6462 0528
address: Room 1502, Building C Poly West Bund Center, No.275, Ruiping Rd, Xuhui Disrict, Shanghai 200232, China